search
Back to results

Comparison of Two Under Knee Lower Limb Bypass Types:Endothelialised Prosthesis Versus Autologous Vein Graft

Primary Purpose

Arteritis

Status
Unknown status
Phase
Phase 2
Locations
France
Study Type
Interventional
Intervention
endothelialised prosthesis
Sponsored by
University Hospital, Bordeaux
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Arteritis focused on measuring Arteritis, femoro popliteal bypass, endothelialised prosthesis, saphenous vein graft, permeability, Doppler echography

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age above 18, male or female, II to IV arteritis level with intermittent limping, under knee femoro popliteal bypass indication. Available saphenous vein, no major trophic trouble, no contra indication to the use of prosthesis. - Exclusion Criteria: -

Sites / Locations

  • Service de chirurgie vasculaire, Hôpital Pellegrin, Place Amélie Raba LéonRecruiting

Outcomes

Primary Outcome Measures

Bypass permeability during 5 years after surgery, assessed trough Doppler echography

Secondary Outcome Measures

Mortality and morbidity, primary and secondary permeability, quality of life, leg salvage, cost/benefit ratio.. All patients will be followed up at 1, 3, 6, and 12 months and each year during 5 years

Full Information

First Posted
September 13, 2005
Last Updated
September 13, 2005
Sponsor
University Hospital, Bordeaux
Collaborators
Ministry of Health, France, W.L.Gore & Associates
search

1. Study Identification

Unique Protocol Identification Number
NCT00221806
Brief Title
Comparison of Two Under Knee Lower Limb Bypass Types:Endothelialised Prosthesis Versus Autologous Vein Graft
Official Title
Randomised Study Comparing Endothelialised Prosthesis and Autologous Vein for Under Knee Revascularisation With Femoro Popliteal Bypass. ePTFE
Study Type
Interventional

2. Study Status

Record Verification Date
September 2005
Overall Recruitment Status
Unknown status
Study Start Date
June 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
June 2012 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
University Hospital, Bordeaux
Collaborators
Ministry of Health, France, W.L.Gore & Associates

4. Oversight

5. Study Description

Brief Summary
The aim of this project is to improve the hemocompatibility of vascular prosthesis with a complete covering of its endoluminal surface with autologous endothelial cells. The objective is to obtain a better bypass permeability with arterial prosthesis replacing low diameter vessels in lower limbs
Detailed Description
Physiological vascular endothelium is an hemocompatible and thrombus resistant surface and none of the materials used for revascularisation owns these properties. The aim of this project is to improve the hemocompatibility of vascular prosthesis with a complete covering of their endoluminal surface with autologous endothelial cells. This strategy, that plans to associate an artificial component of synthetic origin and cellular component is a bioartificial vascular substitute concept. First results obtained by an austrian team are really encouraging (with more than 100 patients during last 10 years). Thus, the main objective of this study is to compare efficacy in terms of grafts with endothelialised PTFE prosthesis with great saphenous autologous vein graft for under knee arterial popliteal revascularisation of lower limbs. This is a phase III, randomised equivalent trial. It is open labelled, with 2 parallel well balanced groups. Forty patients will be randomised. A short segment of the cephalic vein will be cut and some blood will be sampled in patients randomised in the ePTFE group. Endothelial cells of the cephalic vein will be isolated, cultured, with autologous serum, and then amplified before sowing of the internal face of PTFE prosthesis, previously covered with a biological glue clinically validated. Before prosthesis implantation, systematic quality controls will be performed. Implantation will be planned 3 weeks after venous sampling. Eventual failure of cellular culture or prosthesis covering will lead to an autologous vein graft. People randomised in the second group will receive an autologous saphenous vein graft. The primary outcome is to demonstrate the equivalence of time dependent permeability rate between endothelialized PTFE and autologous vein graft. Equivalence between both technics would allow to preserve autologous saphenous vein for later distal bypasses (where it is the best technic) or for coronary bypasses.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Arteritis
Keywords
Arteritis, femoro popliteal bypass, endothelialised prosthesis, saphenous vein graft, permeability, Doppler echography

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (false)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
endothelialised prosthesis
Primary Outcome Measure Information:
Title
Bypass permeability during 5 years after surgery, assessed trough Doppler echography
Secondary Outcome Measure Information:
Title
Mortality and morbidity, primary and secondary permeability, quality of life, leg salvage, cost/benefit ratio.. All patients will be followed up at 1, 3, 6, and 12 months and each year during 5 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age above 18, male or female, II to IV arteritis level with intermittent limping, under knee femoro popliteal bypass indication. Available saphenous vein, no major trophic trouble, no contra indication to the use of prosthesis. - Exclusion Criteria: -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laurence Bordenave, MD-PhD
Organizational Affiliation
Institut National de la Santé Et de la Recherche Médicale, France
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Jacques Demotes-Mainard, MD-PhD
Organizational Affiliation
CIC INSERM-CHU de Bordeaux
Official's Role
Study Chair
Facility Information:
Facility Name
Service de chirurgie vasculaire, Hôpital Pellegrin, Place Amélie Raba Léon
City
Bordeaux
ZIP/Postal Code
33076
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dominique Midy, MD
Phone
+33 55679 5526
Email
dominique.midy@chu-bordeaux.fr
First Name & Middle Initial & Last Name & Degree
Laurence Bordenaave, MD-PhD
Phone
+33 557656565
Email
laurence.bordenave@u-bordeaux2.fr
First Name & Middle Initial & Last Name & Degree
Dominique Midy, MD

12. IPD Sharing Statement

Learn more about this trial

Comparison of Two Under Knee Lower Limb Bypass Types:Endothelialised Prosthesis Versus Autologous Vein Graft

We'll reach out to this number within 24 hrs